{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:24:34Z","timestamp":1790447074911,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.amepre.2023.08.016","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T11:27:27Z","timestamp":1692876447000},"page":"10-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada"],"prefix":"10.1016","volume":"66","author":[{"given":"Mary Clare","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiru","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-8950","authenticated-orcid":false,"given":"Samuel","family":"Tobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-393X","authenticated-orcid":false,"given":"Jane A.","family":"Buxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6684-2030","authenticated-orcid":false,"given":"Mark","family":"Lysyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Tupper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2470-438X","authenticated-orcid":false,"given":"Lianping","family":"Ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2023.08.016_bib0001","unstructured":"Public Health Agency of Canada. Opioid and stimulant-related harms in Canada. https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/. Accessed June 20, 2023."},{"key":"10.1016\/j.amepre.2023.08.016_bib0002","unstructured":"National Institute on Drug Abuse. Drug overdose death rates.https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates. Accessed August 11, 2023."},{"issue":"2","key":"10.1016\/j.amepre.2023.08.016_bib0003","doi-asserted-by":"crossref","first-page":"56","DOI":"10.24095\/hpcdp.39.2.03","article-title":"At-a-glance-the impact of poisoning-related mortality on life expectancy at birth in Canada, 2000 to 2016","volume":"39","author":"Orpana Heather","year":"2019","journal-title":"Health Promot Chronic Dis Prev Can"},{"issue":"293","key":"10.1016\/j.amepre.2023.08.016_bib0004","first-page":"1","article-title":"Mortality in the United States, 2016","volume":"293","author":"Kochanek","year":"2017","journal-title":"NCHS Data Brief"},{"issue":"2","key":"10.1016\/j.amepre.2023.08.016_bib0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/aje\/kwab129","article-title":"Time-series analysis of fentanyl concentration in the unregulated opioid drug supply in a Canadian setting","volume":"191","author":"Tobias","year":"2022","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amepre.2023.08.016_bib0006","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugpo.2018.10.001","article-title":"Drug checking as a potential strategic overdose response in the fentanyl era","volume":"62","author":"Laing","year":"2018","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.amepre.2023.08.016_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109427","article-title":"Variability in the unregulated opioid market in the context of extreme rates of overdose","volume":"235","author":"Larnder","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.amepre.2023.08.016_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103741","article-title":"Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada","volume":"106","author":"Klaire","year":"2022","journal-title":"Int J Drug Policy"},{"issue":"3","key":"10.1016\/j.amepre.2023.08.016_bib0009","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/add.15734","article-title":"Drug checking services for people who use drugs: a systematic review","volume":"117","author":"Maghsoudi","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.amepre.2023.08.016_bib0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","article-title":"Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States","volume":"63","author":"Peiper","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.amepre.2023.08.016_bib0011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12954-018-0276-0","article-title":"Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study","volume":"16","author":"Goldman","year":"2019","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.amepre.2023.08.016_bib0012","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12954-018-0252-8","article-title":"Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada","volume":"15","author":"Karamouzian","year":"2018","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.amepre.2023.08.016_bib0013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12954-018-0213-2","article-title":"High willingness to use rapid fentanyl test strips among young adults who use drugs","volume":"15","author":"Krieger","year":"2018","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.amepre.2023.08.016_bib0014","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.drugalcdep.2018.06.020","article-title":"Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting","volume":"190","author":"Tupper","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.amepre.2023.08.016_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"2","key":"10.1016\/j.amepre.2023.08.016_bib0016","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/02791072.2017.1394508","article-title":"Sold as heroin: perceptions and use of an evolving drug in Baltimore, MD","volume":"50","author":"Mars","year":"2018","journal-title":"J Psychoactive Drugs"},{"issue":"5","key":"10.1016\/j.amepre.2023.08.016_bib0017","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/add.14474","article-title":"Illicit fentanyls in the opioid street market: desired or imposed?","volume":"114","author":"Mars","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.amepre.2023.08.016_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2018.09.006","article-title":"Characterizing fentanyl-related overdoses and implications for overdose response: findings from a rapid ethnographic study in Vancouver, Canada","volume":"193","author":"Mayer","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"10.1016\/j.amepre.2023.08.016_bib0019","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/add.14614","article-title":"How the complex pharmacology of the fentanyls contributes to their lethality","volume":"114","author":"Gill","year":"2019","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.amepre.2023.08.016_bib0020","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/08897077.2020.1864569","article-title":"The utility of visual appearance in predicting the composition of street opioids","volume":"42","author":"McCrae","year":"2021","journal-title":"Subst Abus"},{"key":"10.1016\/j.amepre.2023.08.016_bib0021","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugpo.2017.05.018","article-title":"The utility of drug checking services as monitoring tools and more: a response to Pirona et al","volume":"45","author":"Gin\u00e9","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"2","key":"10.1016\/j.amepre.2023.08.016_bib0022","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/aje\/kwab233","article-title":"Invited commentary: drug checking for novel insights into the unregulated drug supply","volume":"191","author":"Dasgupta","year":"2022","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.amepre.2023.08.016_bib0023","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1037\/pha0000452","article-title":"Drug checking at dance festivals: a review with recommendations to increase generalizability of findings","volume":"29","author":"Palamar","year":"2021","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.amepre.2023.08.016_bib0024","unstructured":"Illicit Drug Overdose Deaths in BC (January 1, 2012 - December 31, 2022). British Columbia Coroners Service. Burnaby BC: Office of the Chief Coroner; 2023."},{"issue":"34","key":"10.1016\/j.amepre.2023.08.016_bib0025","doi-asserted-by":"crossref","first-page":"E967","DOI":"10.1503\/cmaj.200191","article-title":"Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada","volume":"192","author":"Crabtree","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.amepre.2023.08.016_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108006","article-title":"Detecting fentanyl using point-of-care drug checking technologies: a validation study","volume":"212","author":"Ti","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.amepre.2023.08.016_bib0027","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/dar.13004","article-title":"Assessing the limit of detection of Fourier-transform infrared spectroscopy and immunoassay strips for fentanyl in a real-world setting","volume":"39","author":"McCrae","year":"2020","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.amepre.2023.08.016_bib0028","unstructured":"Vibrational Spectroscopy Software Opus. OPUS Package: QUANT. Bruker. https:\/\/www.bruker.com\/en\/products-and-solutions\/infrared-and-raman\/opus-spectroscopy-software\/quantification.html. Updated 2006. Accessed June 27, 2023."},{"key":"10.1016\/j.amepre.2023.08.016_bib0029","unstructured":"Tobias S, Ti L. An assessment of two point-of-care fentanyl quantification methods using Fourier-transform infrared spectroscopy. Vancouver, BC: BC Centre on Substance Use.https:\/\/drugcheckingbc.ca\/wp-content\/uploads\/sites\/2\/2021\/03\/Quantification-Methods-Report-Feb-2021.pdf. Published 2021. Accessed June 27, 2023."},{"key":"10.1016\/j.amepre.2023.08.016_bib0030","unstructured":"Fentanyl Quantification and Messaging. BC Centre on Substance Use Drug Checking Project.https:\/\/drugcheckingbc.ca\/wp-content\/uploads\/sites\/2\/2021\/11\/2021-11-01-Fentanyl-Quantifcation-and-Messaging.pdf. 2021. Accessed June 20, 2023."},{"key":"10.1016\/j.amepre.2023.08.016_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102661","article-title":"An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples","volume":"77","author":"Green","year":"2020","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.amepre.2023.08.016_bib0032","unstructured":"Population Estimates & Projections for British Columbia. BC Stats. https:\/\/bcstats.shinyapps.io\/popApp\/. Published 2021. Accessed April 25, 2022."},{"issue":"10","key":"10.1016\/j.amepre.2023.08.016_bib0033","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/add.14643","article-title":"Understanding and using time series analyses in addiction research","volume":"114","author":"Beard","year":"2019","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.amepre.2023.08.016_bib0034","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1360-0443.2009.02887.x","article-title":"Ambient temperature and risk of death from accidental drug overdose in New York City, 1990\u20132006","volume":"105","author":"Bohnert","year":"2010","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.amepre.2023.08.016_bib0035","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1360-0443.2005.01094.x","article-title":"Effects of a sustained heroin shortage in three Australian States","volume":"100","author":"Degenhardt","year":"2005","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.amepre.2023.08.016_bib0036","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.2105\/AJPH.2015.302843","article-title":"Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature","volume":"105","author":"Martins","year":"2015","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.amepre.2023.08.016_bib0037","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugpo.2014.09.009","article-title":"\u201cIt's Russian roulette\u201d: adulteration, adverse effects and drug use transitions during the 2010\/2011 United Kingdom heroin shortage","volume":"26","author":"Harris","year":"2015","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.amepre.2023.08.016_bib0038","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drugpo.2014.09.002","article-title":"How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia","volume":"26","author":"Horyniak","year":"2015","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.amepre.2023.08.016_bib0039","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12889-020-8205-z","article-title":"Correlations between opioid mortality increases related to illicit\/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada","volume":"20","author":"Fischer","year":"2020","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.amepre.2023.08.016_bib0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0376-8716(98)00159-8","article-title":"Fluctuations in heroin purity and the incidence of fatal heroin overdose","volume":"54","author":"Darke","year":"1999","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.amepre.2023.08.016_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107779","article-title":"The rapidly changing US illicit drug market and the potential for an improved early warning system: evidence from Ohio drug crime labs","volume":"208","author":"Rosenblum","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"33","key":"10.1016\/j.amepre.2023.08.016_bib0042","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl law enforcement submissions and increases in synthetic opioid\u2013involved overdose deaths \u201327 States, 2013\u20132014","volume":"65","author":"Gladden","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.amepre.2023.08.016_bib0043","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.amepre.2023.08.016_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108580","article-title":"Shifts in drug seizures in the United States during the COVID-19 pandemic","volume":"221","author":"Palamar","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.amepre.2023.08.016_bib0045","unstructured":"Wastewater analysis suggests that consumption of fentanyl, cannabis and methamphetamine increased in the early pandemic period. Statistics Canada. https:\/\/www150.statcan.gc.ca\/n1\/daily-quotidien\/210726\/dq210726a-eng.htm. Published 2021. Accessed June 3, 2023."},{"issue":"9","key":"10.1016\/j.amepre.2023.08.016_bib0046","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/add.14664","article-title":"Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic","volume":"114","author":"Irvine","year":"2019","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.amepre.2023.08.016_bib0047","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/dar.13580","article-title":"Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies","volume":"42","author":"Crepeault","year":"2023","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.amepre.2023.08.016_bib0048","unstructured":"Statistical Reports on Deaths in British Columbia. British Columbia Coroners Service. https:\/\/www2.gov.bc.ca\/gov\/content\/life-events\/death\/coroners-service\/statistical-reports. 2023. Accessed June 27, 2023."}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379723003422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379723003422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:10:17Z","timestamp":1760083817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379723003422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0749379723003422"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2023.08.016","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2023.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}